Viral Load Monitoring of ART: Feasibility & Affordability of Scale up IAS, Kuala Lumpur, 1 st July 2013 Presented by: Nalinikanta Rajkumar, CoNE.

Slides:



Advertisements
Similar presentations
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Advertisements

Contribution of Economics to Operational Research for Evaluation of Scaling Up Access to HIV Care & Treatment in Developing Countries Presentation by Pr.
High rates of survival, virologic suppression and immune reconstitution among patients receiving second-line ART in the Indian national programme B.B.
MSF Experience on Use of HIV Viral Load testing in Myanmar.
Simplification, cost-reduction strategies and examples from the field Teri Roberts Diagnostics Advisor Médecins Sans Frontières, Access Campaign 7th.
HIV in the United Kingdom: 2013 HIV and AIDS Reporting Section Centre for Infectious Disease Surveillance and Control (CIDSC) Public Health England London,
Trends in Antiretroviral Drugs Prescribing at Public Health Facilities in Ethiopia: Compliance to Treatment Guidelines Authors: Hailu Tadeg and Negussu.
Treatment challenges of 2 nd /3 rd line HIV/AIDS, hepatitis-C in Seychelles BY DR LOUINE MOREL.
Dr Susan Zimba –Tembo Professional Officer – WHO 1 st March 2013, Crest Golf Hotel.
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
ART in Resource-limited settings : Progress and Challenges Dr. B. B. Rewari MD,FRCP,FICP,FIACM,FGSI,FIAMS,FIMSA, NPO (ART) India 21 st July 2014, Adult.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
How to IMPLEMENT responses. Who and when ? IMMEDIATEPERIODICLONG TERM Region National Woreda Facility Comm’ty Level and timing of action.
experience from Lesotho
2 About HIV: Teaching Tool. About HIV: A teaching tool © 2nd edition 2006 This tool was developed by the François-Xavier Bagnoud Center at the University.
A Webinar Hosted by The National Harm Reduction Coalition The National Black Leadership Commission on AIDS The Coalition for Positive Health Empowerment.
Inputs to a case-based HIV surveillance system. Objectives  Review HIV case definitions  Understand clinical and immunologic staging  Identify the.
1Management Sciences for Health A LABORATORY BASED APPROACH TO REDUCE LOSS TO FOLLOW UP OF HIV POSITIVE CLIENTS.
PMTCT at Different Levels of Care: The Uganda Experience Dr. Saul Onyango National PMTCT Coordinator Ministry of Health 1 1.
ABSTRACT Background: A retrospective medical record review was conducted to evaluate implementation of the Public Health Service recommendations for laboratory.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Washington D.C., USA, July 2012www.aids2012.org Estimating the Costs and Impacts of HIV/AIDS Programs for Botswana Examples of the ART Program and.
ACCESS TO TREATMENT BY PEOPLE LIVING WITH HIV IN ZAMBIA Presented by: Kunyima Lifumbela Banda Network of Zambian people living with HIV/AIDS (NZP+)
1 Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
USERS’ INVOLVEMENT IN MENTAL HEALTH WORK. By Sylvester Katontoka
2009 Recommendations for Antiretroviral Therapy in Adults and Adolescents Summary of WHO Rapid Advice December 2009 Source: WHO HIV/AIDS Department.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Rights of PLWHA in Hungary Application of Patients’ Rights in Cross-Border Health Care Regional meeting and workshop by Ferenc Bagyinszky Hungarian Civil.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Office of Overseas Programming & Training Support (OPATS) Treatment Adherence HIV Care, Support, and Treatment.
NURSETRI, Nursing role in HIV care : an overview Jane Bruton Clinical Research Nurse.
The Positive Predictive Value of World Health Organization (WHO) Immunologic Criteria for Treatment Failure in a Public Health Antiretroviral Delivery.
Health systems barriers to adherence in antiretroviral treatment programmes in rural South Africa Dr Brian van Wyk School of Public Health University of.
The WHO HIV Drug Resistance Strategy Presented by Dr. Don Sutherland Prepared by: Dr. Don Sutherland Dr Silvia Bertagnolio Dr Diane Bennett HIV Drug Resistance.
ZIMBABWE AIDS CARE FOUNDATION NEWLANDS CLINIC Virological Outcomes in Adult Patients on Second Line ART, at Newlands Clinic Dr S. Bote.
Millennium Development Goals Carla AbouZahr Coordinator, Statistics, Monitoring and Analysis Department of Health Statistics and Informatics World Health.
Livesy Abokyi Kintampo Health Research Centre 9 th INDEPTH AGM th October,2009 Pune, INDIA.
Fabio Mesquita, MD, PhD Director of the Brazilian Ministry of Health’s HIV/AIDS and Viral Hepatitis Department July 23th, 2014 TasP – Leadership.
Module 3: Management of Patients on Antiretroviral Therapy Unit 2: Initiation and Monitoring of ART in Adults and Adolescents.
Sub module 3 Pre-ART and ART registers. Purpose of registers Key individual information for: Facilitating patient management by the identification of.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
Treatment Failure HAIVN Harvard Medical School AIDS Initiative in Vietnam.
STRATEGIC INFORMATION FOR ACTION IN VIET NAM 6 th Viet Nam National Scientific Conference 24 November 2015 Ha Noi, Viet Nam Amitabh Bipin SUTHAR, PharmD,
HIV & AIDS GENERAL AWARENESS. Why should you know about HIV & AIDS ? HIV infection is preventable with correct knowledge and adoption of safe practices.
NFM: Modular Template Measurement Framework: Modules, Interventions and Indicators LFA M&E Training February
Dr. Prosper Chonzi MBChB, MPH, MBA Director of Health Harare City 30 November 2015 Harare – A Fast Track City.
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
1 Uses of Data from the WHO HIV Drug Resistance Strategy: 1. Monitoring of HIVDR emerging in treated groups in sentinel ART clinics HIV Drug Resistance.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Clinic systems should be adapted to maximize the benefits of point-of-care CD4 technology Point-of-Care CD4 Systems Integration in Uganda December 2011.
Durban, July 20th 2016 Ruggero Giuliani MSF - Mozambique
Presented to the AIDS 2016 Conference
2017 Key Considerations for adolescents and children & Key populations
Validating Definitions of Antiretroviral Treatment Failure in Malawi
Jeopardy Game Hosted by PHDP Jamaica MODULE 4 Treatment Literacy.
Simple assessments of adherence to antiretorviral therapy predict virologic failure in HIV+ patients in Lusaka, Zambia Ronald A. Cantrell, MPH University.
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
Utilizing research as an opportunity to strengthen
Implementation of the Appointment Spacing Model of Differentiated Service Delivery in Ethiopia: Successes and Challenges Tamrat Assefa1, Zenebe Melaku1,
VL patient support: General education at different levels
The role of CD4 in patient monitoring Amsterdam July 2018
Dr. Velephi Okello, Principal Investigator, MaxART Trial
EVALUATION OF ANTIRETROVIRAL THERAPY FOLLOWED BY AN EDUCATIONAL INTERVENTION TO INCREASE APPROPRIATE USE IN ZIMBABWE.
Digital Health-eMpower in Vihaan
VL Monitoring updates Dr Miriam Murungi.
From toward HIV Elimination with Boosted-Integrated Active HIV Case Management (B-IACM) in Cambodia Dr. Penh Sun LY, Director, NCHADS Presented.
Towards the last 90% of the 90:90:90 strategy: A review of viral suppression rates in a HIV program in Central and Eastern Kenya Dr Moses Kitheka,
Petchsri Sirinirund Advisor to HIV/AIDS Policy and Programme
Introduction and current status of viral load access
Presentation transcript:

Viral Load Monitoring of ART: Feasibility & Affordability of Scale up IAS, Kuala Lumpur, 1 st July 2013 Presented by: Nalinikanta Rajkumar, CoNE

About CoNE Community Network for Empowerment (CoNE) is a state level network of community based organisations (CBOs) of people who use drugs in Manipur, India contributing to the state health response related to drug use including HIV and other blood borne viruses and also take up the issues and problems faced by people who use drugs at the state and national level. Key Strategic focus Areas: Watch Dog Advocacy Crisis Intervention Research

Manipur  A small State in North east region of India  Geographically isolated from the rest of India  Characterised by multiple sources of conflict including a longstanding civil insurgent struggle  Poverty & Unemployment  Poor health infrastructure in all the districts other than Imphal (Capital of Manipur)  Approximately 2% of the population in Manipur inject drugs (Total population: 2.8 million)  Highest prevalence of HIV in the country %

Loktak lake: The largest freshwater lake in North east India)

HIV Scenario in India 2012 Adult (15-49 years) HIV prevalence = 0.27% No. of PLHIV = 20,88,642(2.8 million) No. of Adult new infections = 1,16,456(0.11 million) No. of annual AIDS related death = 1,47,729(0.14) million) No. of PLHIVs on first line ART= (0.48 million) No. of PLHIVs on second line ART= Manipur No. of PLHIV in Manipur = 42,116 (till oct.2012) No. of PLHIV registered in ART centre = 22,750

Why do we need viral load testing for HIV management? Viral Load testing for routine monitoring to ensure adherence to treatment and timely switch to second line or alternate first line regimens on failure of first line treatment WHO guideline on use of Viral Load If resources permit, use viral load in a routine approach, with the objective of detecting failure earlier than would be the case if immunological and/or clinical criteria were used to define failure.

Viral Load in India: National AIDS Control guidelines Decision to switch from first line to alternate first line ART and second line ART resides with State AIDS Clinical Expert Panel (SACEP) SACEP to meet on weekly basis- to review the case history, order the viral load testing and approve initiation of second line ART for treatment failure and use of alternative regimens. Currently, 7 VL testing centres in India

Criteria for second line evaluation CD4 cell counts declined to pre-ART levels CD4 cell counts had dropped to less than 50% of their highest on-treatment level Failed to reach a CD4 cell count of 100/mm³ If PLHIV developed a World Health Organization stage 3 or 4 AIDS-defining illness.

Dolly, 18 years started her ART in In January 2007, her CD4 count was 393 cells/cu.mm (highest CD4 since the initiation of ART.) It dropped to 107 in January 2011 and she was referred by ART Centre for case review by SACEP for second line ART. She had to wait for 2 months for the next SACEP meeting to take place and was compelled to continue the first line treatment. Unfortunately, she fell very sick at that time and could not attend the meeting. Meanwhile, she was advised to go for further clinical investigations to strengthen her case. Due to increase in her CD4 count level, she was advised not to do her viral load test. December 2011, she was advised by SACEP to start with first line alternative regimen without doing a viral load testing. Her condition improved a bit after switching from d4T to TDF for a while. However, during the entire process of treatment she suffered from numbness of legs, loss of appetite & headache etc. By September 2012 her CD4 count dropped to 57cells/cu.mm. Patient’s Experience

She was admitted to hospital where there was no any further discussion for taking her case in the next SACEP meeting except giving I.V. fluids. She was discharged in two weeks from the hospital without any sign of improvement and despite of her grandmother’s repeated requests for further treatment. She was admitted again after a day due to severe sickness to hospital. The physician suggested the grandparents to shift her to RIMS as this was case of second line ART initiation. Program Director, RIMS (SACEP member) who promised to look into the matter personally and ensured that she will be provided second line immediately. With the hope of getting second line ART she was brought from casualty of JNIMS and admitted again at RIMS casualty on 2 nd October But, regrettably before getting her life saving drugs she expired on that day. This is just the one of the many patient’s experience of accessing second line treatment.

Viral load facilities in India: Problems Viral load testing is not routinely used in India First line treatment failure testing is based upon clinical and immunological failure criteria Only the expert panel-SACEP- will determine eligibility criteria for VL confirmatory testing Doctor at ART Centre can only refer to SACEP

Challenges faced in accessing second line ART Irregular SACEP meetings – held monthly/bi-monthly Non availability of viral load machine in many States Blood sample for viral load send to Kolkata for testing (Take minimum 1 month to get result), condition- minimum no. of samples to be sent – 10 Mandatory physical presence of the patient at SACEP meeting - even if the person is bed ridden Non acceptance of viral load testing from private sector Repetitive clinical investigation CD4 count result inconsistent.

Our Demands Accessibility to viral load testing on routine basis. Remove structural barriers viz. SACEP. Viral load testing as a treatment monitoring tool in resource-limited settings. “Undetectable Viral Load for us means empowerment as we then can concentrate on other work instead of worrying about our health.”